Change of flow-mediated dilation in the forearm after 6 months using the protease inhibitor atazanavir in a potent antiviral therapy combination compared with a combination including current proteinase inhibitor.
Changes in plasma lipid profiles and further clinical chemistry parameters after 6 months of treatment compared to baseline.
18 Years to 65 Years (Adult)
March 14, 2007
May 27, 2009
University Hospital Zurich, Infectiology Zurich, ZH, Switzerland
† Study has passed its completion date and status has not been verified in more than two years.